Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility
暂无分享,去创建一个
David I Stuart | Tulio de Oliveira | Peter Skinhøj | E Yvonne Jones | D. Stuart | B. Chesebro | A. McMichael | A. Iversen | T. de Oliveira | E. Jones | B. L. Walter | Andrew J McMichael | Brandon L Walter | Andrew E Armitage | Stephen C Graham | Bruce Chesebro | Astrid Kn Iversen | S. C. Graham | P. Skinhøj | A. Armitage
[1] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[2] F. Konotey-Ahulu. AIDS IN SUB-SAHARAN AFRICA , 1988, The Lancet.
[3] B. Chesebro,et al. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages , 1991, Journal of virology.
[4] B. Chesebro,et al. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.
[5] D. Hunter,et al. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. , 1993, Epidemiology.
[6] B. Chesebro,et al. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. , 1995, Virology.
[7] J. Nkengasong,et al. The puzzle of HIV‐1 subtypes in Africa , 1997, AIDS.
[8] R. Doms,et al. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. , 1997, The Journal of infectious diseases.
[9] J. Mullins,et al. Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. , 1998, Journal of Infectious Diseases.
[10] J. Mullins,et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. , 1998, The Journal of infectious diseases.
[11] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[12] J. Andersson,et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. , 1998, The American journal of pathology.
[13] M. Carrington,et al. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission. , 1999, The Journal of infectious diseases.
[14] G. Learn,et al. Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women. , 1999, Journal of acquired immune deficiency syndromes.
[15] M. McElrath,et al. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. , 1999, Journal of immunology.
[16] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[17] Nathan A. Baker,et al. Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Hayes,et al. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa , 2001, AIDS.
[19] R. Hayes,et al. Commercial sex and the spread of HIV in four cities in sub-Saharan Africa , 2001, AIDS.
[20] G. Learn,et al. Human Immunodeficiency Virus Type 1 Env Sequences from Calcutta in Eastern India: Identification of Features That Distinguish Subtype C Sequences in India from Other Subtype C Sequences , 2001, Journal of Virology.
[21] M. Peeters,et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. , 2002, The Journal of infectious diseases.
[22] Emmanuel G. Cormier,et al. The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor , 2002, Journal of Virology.
[23] Neff Walker,et al. Estimated Global Distribution and Regional Spread of HIV‐1 Genetic Subtypes in the Year 2000 , 2002, Journal of acquired immune deficiency syndromes.
[24] David Swofford,et al. PAUP* 4.0 : Phylogenetic Analysis Using Parsimony , 2002 .
[25] Michael Worobey,et al. Epidemiology: Sexual transmission of HIV in Africa , 2003, Nature.
[26] O. Gascuel,et al. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. , 2003, Systematic biology.
[27] S. Lai,et al. Characterization of HIV type 1 heterosexual transmission in Yunnan, China. , 2003, AIDS research and human retroviruses.
[28] Robyn L Stanfield,et al. Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor , 2004, Journal of Virology.
[29] F. Gotch,et al. Ex vivo analysis of HIV‐1 co‐receptors at the endocervical mucosa of women using oral contraceptives , 2004, BJOG : an international journal of obstetrics and gynaecology.
[30] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[31] W. Paxton,et al. Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies , 2004, Journal of Virology.
[32] W. Fawzi,et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D , 2004, AIDS.
[33] Bette T. Korber,et al. Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission , 2004, Science.
[34] Stephen J O'Brien,et al. Human genes that limit AIDS , 2004, Nature Genetics.
[35] Zheng Rong Yang,et al. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins , 2005, Bioinform..
[36] C. Rousseau,et al. Subtype C Is associated with increased vaginal shedding of HIV-1. , 2005, The Journal of infectious diseases.
[37] Yang Liu,et al. Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B , 2005, Journal of Virology.
[38] G. Learn,et al. Preferential detection of HIV subtype C' over subtype A in cervical cells from a dually infected woman. , 2005, AIDS.
[39] N. Miller. HIV in South Africa. , 2005, Midwifery today with international midwife.
[40] B. Chesebro,et al. Role of Low CD4 Levels in the Influence of Human Immunodeficiency Virus Type 1 Envelope V1 and V2 Regions on Entry and Spread in Macrophages , 2005, Journal of Virology.
[41] Dorothy M. Lang,et al. Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels , 2005, Journal of Virology.
[42] M. Soares,et al. HIV-1 subtype C dissemination in southern Brazil , 2005, AIDS.
[43] M. McElrath,et al. Combined Effect of CCR5-Δ32 Heterozygosity and the CCR5 Promoter Polymorphism −2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission , 2005, Journal of Virology.
[44] P. Tighe,et al. HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix , 2005, AIDS.
[45] Bette Korber,et al. Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.
[46] W. Borkowsky,et al. CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men , 2006, AIDS.
[47] J. Overbaugh,et al. Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.
[48] G. Ciaramella,et al. Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry , 2006, Journal of Virology.
[49] O. Schwartz,et al. Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes , 2006, Journal of Virology.
[50] Xiping Wei,et al. Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[51] Louise V Wain,et al. Adaptation of HIV-1 to its human host. , 2007, Molecular biology and evolution.
[52] M. Nei,et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.
[53] Peter D. Kwong,et al. Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.
[54] B. Berkhout,et al. In HIV-1 pathogenesis the die is cast during primary infection , 2007, AIDS.
[55] M. McElrath,et al. Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1 , 2007, Immunity.